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Theobjectiveofthisproof-of-conceptstudywastodevelopaplatformforcontrolleddrugdeliverybasedonsilkﬁbroin(SF)andto
explorethefeasibilityofusingSFinoraldrugdelivery.TheSF-containingmatrixeswerepreparedviaspray-dryingandﬁlmcasting,
and the release proﬁle of the model drug naproxen sodium was evaluated. Attenuated total reﬂectance Fourier transform infrared
spectroscopy (FTIR) has been used to observe conformational changes in SF- and drug-containing compositions. SF-based ﬁlms,
spray-dried microparticles, and matrixes loaded with naproxen were prepared. Both FTIR spectra and in vitro dissolution data
demonstrated that SF β-sheet conformation regulates the release proﬁle of naproxen. The controlled release characteristics of the
SF-containing compositions were evaluated as a function of SF concentration, temperature, and exposure to dehydrating solvents.
The results suggest that SF may be an attractive polymer for use in controlled drug delivery systems.
1.Introduction
Silk ﬁbroin (SF) is a natural polymer produced by a variety
of insects and spiders. The best characterized silks are the
dragline silk from the spider Nephila clavipes and the cocoon
silk from the domesticated silkworm Bombyx mori,w h i c h
has been used in textile production clinical sutures, and
more recently as a scaﬀold for tissue regeneration [1–3].
Bombyx mori silk is composed of a ﬁlament core pro-
tein, silk ﬁbroin, and a glue-like coating consisting of a non-
ﬁlamentous protein, sericin. SF is characterized by repetitive
hydrophobicandhydrophilicpeptidesequences[4]andcon-
sists of heavy and light chain polypeptides of ∼390kDa
and ∼26kDa, respectively, linked by a disulﬁde bond at the
C-terminus of the two subunits. The primary structure of
Bombyx mori SF protein is characterized by the presence of
three amino acids in a roughly 3:2:1 ratio: glycine (45%),
alanine (30%), and serine (12%); and the sequence is dom-
inated by [Gly-Ala-Gly-Ala-Gly-Ser]n. SF chains also con-
tain amino acids with bulky and polar side chains, in par-
ticular tyrosine, valine, and acidic amino acids [5]. The
repetitivesequenceinhydrophobicresiduesdominatestheβ-
sheet structure, forming crystalline regions in SF ﬁbers and
ﬁlms. The formation of these β-sheets results in insolubility
inwater.Hydrophobicregionsofsilkﬁbroininaqueoussolu-
tion assemble physically by hydrophobic interactions and
eventually organize into hydrogels.
Silk ﬁbroin exhibits impressive mechanical properties as
well as biocompatibility making it an attractive biomaterial
andscaﬀoldfor tissue engineering. The ﬁbroin protein is one
kind of biological materials used for artiﬁcial skin and other
medical applications. As a result of its biodegradability [6],
SF was evaluated for several biomedical applications. In one
example [7], SF-based ﬁlms with a thickness of 10–100μm
were developed for acceleration of wound healing and could
be peeled oﬀ without damaging the newly formed skin.
As such, the application of wound protective membranes
made from SF was investigated [8]. SF is considered a suit-
able material for skeletal tissue engineering because of its
good oxygen and water-vapor permeability and its minimal
inﬂammatory reaction in vivo [6, 9]. As reported previously
[10], ﬁbroin hydrogel scaﬀolds were prepared from SF2 Journal of Drug Delivery
aqueous solution with addition of 30% glycerol to promote
in situ bone regeneration. Also, SF was investigated as the
substratum for the culture of animal cells in place of col-
lagen [11]. In another application, the aqueous SF solution
was used to prepare a membrane for immobilization of
Aspergillus niger, glucose-oxidase, and Pseudomonas ﬂuo-
rescens lyophilized cells [12]. A novel biocompatible blend
[13] was prepared from recombinant human-like collagen
(RHLC) and used as a scaﬀold material for hepatic tissue
engineering applications. Solution blending was used to
incorporate RHLC with SF to enhance the blend ﬁlms bio-
compatibility and hydrophilicity, while maintaining elastic-
ity. In yet another demonstration of SF utility, three-dimen-
sional microperiodic scaﬀolds for tissue engineering were
produced from aqueous solutions of regenerated Bombyx
mori silk [14]. The scaﬀolds supported human bone-mar-
row-derived mesenchymal stem cell (hMSC) adhesion and
growth.
Sericin and ﬁbroin have been recently explored in the
ﬁeld of drug delivery. SF was studied as an organic polymer
for controlled drug delivery [4], in which dextrans of diﬀer-
ent molecular weights, as well as proteins, were physically
entrapped into the drug delivery device during processing
into ﬁlms. The release behavior of benfotiamine, a vitamin
B1 derivative, from SF gel was investigated [15]. Micro-
spheres were fabricated from an aqueous SF solution by
laminarjetbreak-upﬂowandwereinvestigatedasaplatform
for controlled drug delivery [16] .T h ea s s e m b l yp r o c e s sw a s
reported for SF particles loaded with small molecule model
drugs, such as alcian blue, rhodamine B, and crystal violet,
produced by an all-aqueous salting out process [17], and it
was demonstrated that the release kinetics of crystal violet is
dependent on the secondary structure of the SF particles.
We attempted to design an oral drug delivery system
based on the ability of SF to undergo conformational tran-
sition from a random coil to a β-sheet form to induce cry-
stallinity and produce an interpenetrating network (IPN).
Several diﬀerent approaches to develop a SF-based drug
delivery system were used: (1) ﬁlm and matrix casting with
varying composition of SF, gelatin, glycerin and the model
drug, and (2) spray drying of SF/model drug solution.
Multiple factors were evaluated for their eﬀect on SF β-
sheetformation,includingsolvents,SFmolecularweight,silk
source, and so forth. The aim of our study is also to under-
stand the silk ﬁbroin processing and control of structure in
connection with design of a controlled release matrix.
2.MaterialsandMethods
2.1. Reagents and Chemicals. Cocoons of Bombyx mori silk-
wormsilkwerekindlyprovidedbyM.Goldsmith(University
of Rhode Island, USA). Low MW (∼14kDa) SF powder was
supplied by Lalilab (Raleigh, USA). Raw silk ﬁber (Grade 5A,
Bombyx mori silk) was purchased from RIA International
LLC (East Hanover, NJ, USA), and Fibro-Silk Powder
(MW ∼ 100kDa) was purchased from Arch Chemicals,
Inc (Atlanta, GA, USA). Both Sephadex G-25 (medium
grade) and sodium carbonate were purchased from J. T.
Baker (Austin, TX, USA). Naproxen sodium was supplied
by RoChem International, Inc (Ronkonkoma, NY, USA).
Sodium dodecyl sulfate and calcium chloride dihydrate were
purchased from Spectrum Chemical (New Brunswick, NJ,
USA). Lithium bromide, calcium nitrate, and potassium
bromidewerepurchasedfromSigma-Aldrich(St.Louis,MO,
USA). Gelatin (Type B, 150 Bloom limed bone, NF) was
obtained from Rousselot (France). Glycerin (USP, Kosher,
vegetable-based) was obtained from Proctor and Gamble
(Cincinnati, OH, USA). All other chemicals were of analyt-
ical or pharmaceutical grade, were purchased from Sigma-
Aldrich, and were used without any additional puriﬁcation.
2.2. Silk Blend Preparation. Silk ﬁbroin aqueous stock solu-
tions were prepared as described previously with some
modiﬁcations[16,18].Brieﬂy,cocoons,silkpowder,orgrade
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solutions of 0.02M Na2CO3, or 0.25% NaCO3/0.25% NaSO4
mixture, rinsed thoroughly with distilled water to remove
the glue-like sericin proteins and dried. Dry degummed silk
ﬁbers were then dissolved in one of the following neutral
solutions of LiBr, Ca(NO3)2 or CaCl2, and then the resulting
solution was dialyzed against distilled water using a Slide-
A-Lyzer dialysis cassette (MWCO 3500, Pierce) or cellulose
membrane tube (MWCO 6000–8000, Sigma-Aldrich) at
room temperature to remove the salt. The completion of
the dialysis process was monitored by conductivity measure-
ment. Undissolved particles were removed by centrifugation.
The ﬁnal concentration of SF aqueous solution was deter-
mined by weighing the residual solid of a known volume
of solution after drying at 60◦C for 2 days. Based on this
determination, the concentration of the silk protein was
approximatelyintherangeof3to4%(w/v).Toprepareﬁlms,
SF solution was transferred to a polystyrene weighing boat
a n da l l o w e dt od r yf o rs e v e r a ld a y sa tr o o mt e m p e r a t u r ei n
a desiccator. SF/gelatin ﬁlms were prepared by mixing the SF
solution with gelatin blends, consisting of gelatin, plasticizer,
and water, and dried in a polystyrene weighing boat at room
temperature in a desiccator for several days.
2.3. Puriﬁcation of Silk Solution by Column Chromatography
Using Sephadex G-25. Separation of salts and SF pro-
tein was performed using a Sephadex G-25 media column
as described in the literature [19]w i t hs o m em o d i ﬁ c a -
tions. SF powder was dissolved in a triad solvent of
CaCl2 :EtOH:H2Owithamoleratioof1:2:8,ataconcen-
tration of 14.4% (w/w), at 60–80◦C, and stirred for 4–6hrs
until fully dissolved and the stock SF solution was diluted
in deionized water to reduce sample viscosity. To a 7.3g
of Sephadex G-25 (medium grade) 42.6g water was added
allowing the Sephadex to swell for at least 3 hours then the
slurry was packed by gravity ﬂow of deionized water (2-3
bedv olumes)ina50mLglassburette.Conductivityofeluent
ﬂowwasmeasureduntil3consecutivefractions(10mLeach)
tested <10μS/cm to ensure removal of contaminating ions
from column before addition of SF solution (7.2% SF).
Fractions were collected every 5–10 minutes for the ﬁrst ∼25
minutes,whileconductivitywascontinuouslymeasuredthen
every 2–5 minutes until the end of the experiment, or until
the conductivity of the eluting fraction returned to a valueJournal of Drug Delivery 3
Table 1: SF Processing Conditions.
Silk type Degumming solution Dissolving solution
Silk worm cocoons—Bombyx mori 0.25% Na2CO3 9.0M LiBr
0.25% Na2SO4 Ca(NO3)2 4H2O:MeOH (75:25)w/w
Grade 5A Raw Silk—Bombyx mori 0.25% Na2CO3 Ca(NO3)2 4H2O:MeOH (75:25)w/w
0.25% C12H25O4SNa CaCl2 :E t O H:H 2O (1:2:8)mole ratio
Silk ﬁbroin powder Not required CaCl2 :E t O H:H 2O (1:2:8)mole ratio
of <10μS/cm. UV absorbance was measured and recorded
for each fraction at 280nm (blank: quartz cuvette ﬁlled with
deionized water). All fractions were placed in the oven at
60◦C for 24 hours, or until all liquid had evaporated, and
the residual net mass was determined for each fraction after
drying.
2.4. Preparation of SF Microparticles. To prepare SF micro-
particles, the model drug naproxen sodium (NS), was dis-
solved in SF solution (silk:naproxen ratios tested: 1:1, 1.5:
1, 2:1, and 3:1) for spray-drying. Naproxen-sodium-con-
taining SF microparticles were prepared using a bench
top spray-dryer (B¨ UCHI B-290 model, Switzerland). The
adjustable parameters included inlet and outlet temperature,
solutionpumpﬂowrate,andtheaspiratorpartialvacuum.In
the present experiments, the inlet temperature ranged from
135 to 200◦C, the pump ﬂow rate was 6-7mL/min, and the
atomizing air ﬂow rate was 600l/h (0.75bar).
2.5. Scanning Electron Microscopy. The morphological char-
acteristics of SF microparticles and cross-sections of Gelatin/
SF blends, both before and after treatment with dehydrating
solvents and before and after drug release experiments, were
examined by scanning electron microscopy (SEM). Samples
of dried ﬁlms were prepared for SEM imaging by ﬂash
freezing in liquid nitrogen and immediately fracturing with
a sharp blade to produce cross-sections. The samples were
then coated with a ∼8nm layer of Au/Pt mist using a sputter
coater. A Hitachi S3200 variable pressure scanning electron
microscope equipped with an E-T secondary electron detec-
tor was used to examine the samples at an accelerating
voltage of 5kV and a working distance of 15mm.
2.6.DynamicLightScattering. Particlesizemeasurementsfor
silk microparticles were also performed using dynamic light
scattering (DLS). A Nicomp ZW380 (Particle Sizing systems,
Inc. Ca) particle sizer at ﬁxed angle (90◦) and 632.8nm was
employed for size distribution measurements. The SF micro-
particles were suspended in an oil matrix at a 1:100 dilution
before measurements.
2.7. Infrared Spectroscopy. FTIR spectra of silk ﬁbroin blend
ﬁlms were collected using a Nicolet 510P spectrometer
equipped with the attenuated total reﬂectance (ATR) acces-
sory. These ﬁlms were cast on the surface of polystyrene
weigh boats directly from solution. Each spectrum for sam-
ples was acquired in transmittance mode with a spectral
range of 4000–400cm−1. FTIR spectra of the SF-containing
microparticleswerecollectedusingaPerkin-ElmerSpectrum
BX FTIR spectrophotometer and NIC380 Avatar OMNI
Sampler apparatus. KBr pellets, containing ∼0.7% (w/w) of
spray-driedpowderwerepreparedusingaCarverPelletPress
with 18,000 lbs applied load. Thin ﬁlms for comparison were
obtained by casting of SF solution on the surface of poly-
styrene weigh boats and were analyzed by FTIR.
2.8. In Vitro Drug Release Studies. The naproxen release
from the ﬁlms, matrixes, and spray-dried microparticles was
studied using Distek Evolution 6100 dissolution system. Two
sets of conditions were used: one-stage method with ap-
paratus 2 (paddle) at 50rpm in 500mL of pH 7.4 phosphate
buﬀer at 37◦C and three-stage method with three pH
buﬀers—simulated gastric ﬂuid (pH 1.2), simulated intes-
tinal ﬂuid (pH 4.8) and pH 7.4 buﬀer. The samples (1.5mL)
at each predetermined time point were analyzed by HPLC
according to naproxen sodium, USP method. The detector
wavelength was set at 272nm and the injection volume was
10μL. The HPLC column used was Inertsil ODS-3 4.6 ×
250mm, 5μm with the column temperature maintained at
25◦C. The mobile phase was a binary mixture of potassium
phosphate buﬀer:acetonitrile (3:2) at pH 3.0 pumped at
ﬂ o wr a t eo f1 . 5m L / m i n .
3. Results
3.1. SilkFibroin Processing. Rawsilk consists of ﬁbrointhat is
bound together by hydrophilic gum-like protein, the sericin.
For use in biomedical applications, silk protein ﬁbroin has
to be dissolved. The dissolution of SF as related to the roles
of salts, alcohol, and water and coagulation of the ﬁbroin
solution was discussed elsewhere [20]. Bombyx mori SF dis-
solves in neutral salt-alcohol systems without degradation.
Lithium bromide—or lithium thiocyanate—ethanol system,
hexaﬂuoroisopropyl alcohol, and calcium nitrate-methanol
systems have been widely used to dissolve silk ﬁbroin. A
summaryoftheprocessingconditionsemployedfordiﬀerent
sources of SF in our research is presented in Table 1.
It usually takes longer time (7-8 hours) at 65–80◦Ct o
dissolve raw Bombyx mori silk using diﬀerent solvent systems
(Table 1), then to dissolve SF powder (4–6 hours). In order
to develop a scalable process we have attempted to separate
SF from salts by Sephadex G-25 media as described in the
literature [19]. The primary purpose of purifying by column
chromatography was to explore the feasibility of a quicker
processing step, in place of dialysis. The two components
were eﬀectively separated using this approach, allowing
for gravimetric analysis as a means of approximating the
mass of either SF protein or CaCl2 salt contained in each4 Journal of Drug Delivery
0
20
40
60
80
100
120
140
160
180
0
5
10
15
20
25
30
35
40
45
Volume eluted
SF (mg)
S
F
(
m
g
)
C
a
C
l
2
s
a
l
t
 
(
m
g
)
CaCl2 salt (mg)
Figure 1: Puriﬁcation of SF solution (7.2%) by Sephadex G-
25 (medium grade) column chromatography using gravity ﬂow.
Elution of SF (– –) and CaCl2 (– –) salt is shown as net dry mass
recovered in each fraction collected, and both are conﬁrmed by UV
absorbanceat280nmandconductivitymeasurements,respectively.
Table 2: FT-IR analysis of partially hydrolyzed SF in blends with
gelatin.
Amide I (cm−1)A m i d e I I ( c m −1)
Pure SF Films
2 kDa SF 1620 —
14 kDa SF 1624 1520
100 kDa SF 1625 1519
SF/gelatin blends
2 kDa SF (1.8%) 1636 1542
12 kDa SF (0.9%) 1632 1540
100 kDa SF (1.4%) 1625 1538
fraction collected (Figure 1). These results demonstrate the
feasibility of separating SF protein dissolved in a highly
concentrated salt solution; however, further characterization
of the SF protein after desalting will be required prior to im-
plementation of this process on a commercial scale.
In order to reduce the processing time we explored the
applicability of diﬀerent sources of silk ﬁbroin. One option
was to eliminate the degumming step and use partially hy-
drolyzed SF, while another option was to use a low-mole-
cular-weight water-soluble SF, thus allowing elimination of
three processing steps: degumming, dissolving, and dialysis.
The ability to form crystalline structure was investigated
for partially hydrolyzed SF at three diﬀerent molecular
weights (100kDa, 14kDa, and 2kDa). Low MW SF (14 and
2kDa) was soluble in water and demonstrated crystalline
secondary structure in pure form as evidenced by FTIR data
presentedinTable 2.However,onlyhigher-molecular-weight
SF (100kDa) was shown to possess β-sheet conformation in
blends with gelatin.
3.2. Eﬀect of Diﬀerent Solvents on β-Sheet Formation. The
eﬀect of glycerin and dehydrating solvents (methanol,
ethanol, and isopropyl alcohol) on formation of β-sheets
was studied for gelatin/silk ﬁbroin compositions. SF/gelatin
compositions with and without glycerin were prepared and
treated with methanol, ethanol, and isopropyl alcohol. The
eﬀect of diﬀerent solvents and presence of glycerin on β-
sheet formation is summarized in Table 3. The eﬀect of
solvents on β-sheet formation showed that ﬁlms treated
with diﬀerent alcohols exhibit the signature of the β-sheet
conformation (silk II structure) at each amide peak: amide
I, which reﬂects the stretching of C=O group along the
SF backbone (shifted from ∼1650cm−1 to 1630cm−1). The
amide II, which originates from N–H deformation, shifts
from ∼1544 to 1536cm−1.A ss e e nf r o mTable 3,i s o p r o p y l
alcohol treatment also gives good crystallizing eﬀect.
The content of SF and glycerin has an impact on the
FTIR signal. Higher SF (SF/G 1:1) content showed higher
ﬁbroin-speciﬁc signal change for amide I after cast-treat-
ment. Interestingly, the untreated ﬁlms (SF/G 1:1) also de-
monstrated the crystallizing eﬀect indicating that glycerin
could induce the formation of β-sheet (Table 3).
3.3.PreparationofDrug-LoadedFilms. Amixtureofdialyzed
SF solution with predetermined amount of gelatin mass
and a model drug was cast on a polystyrene weighing boat
to prepare SF ﬁlms. Cast ﬁlms were treated with meth-
anol, ethanol, and isopropyl alcohol or exposed to water
vapor. Gelatin mass was prepared from gelatin, water, and
plasticizer (glycerin) by initially mixing water and plasticizer
with gelatin granules followed by heating at ∼60◦C until a
clear gel was obtained.
3.4. Development of a Sustained Release Matrix. SF-contain-
ing compositions were prepared, using naproxen sodium, as
a model drug and presented in Table 4. These compositions
are calculated based on weight after the ﬁlms and matrixes
havecompletelydried,beforeperformingdissolutiontesting.
The characterization of naproxen release from SF-con-
taining matrixes and ﬁlms was performed at pH 7.4. Drug
release from amorphous carrier (control ﬁlm) was charac-
terized by an initial burst exceeding 75% of the theoretical
amount of naproxen in 5 minutes demonstrating immediate
release of the model drug. For SF-containing ﬁlms the initial
burst was markedly reduced (∼60% in 5 minutes). Studies
(Figure 2) indicated that the time needed to achieve over
80% dissolution for naproxen-loaded ﬁlms is 15 minutes
as opposed to 5 hours for the SF-containing matrix. These
results demonstrate the formation of crystalline SF network
in silk and gelatin blends which signiﬁcantly retard the
release of naproxen compared to amorphous gelatin.
3.5. Development of SF Microparticles for Controlled Release.
Although the SF/gelatin/glycerin blends described above
demonstrated feasibility for use as a controlled drug delivery
system,anotherapproachutilizingmicroparticlescontaining
only SF and water was explored. SF-containing compositions
loaded with naproxen sodium were prepared via spray-
drying and are presented in Table 5.
The spray-dried powders with diﬀerent ratios of SF:NS
(1:1,1.5:1,2:1and3:1)wereencapsulatedin2-piecehard
gelatin capsules, and the release of naproxen sodium wasJournal of Drug Delivery 5
Table 3: Eﬀect of diﬀerent solvents on β-sheet formation.
SF/gelatin composition Solvent Absorption bands (cm−1)
Amide I Amide II
SF/G (1:3) without glycerin
Untreated 1646.3 1540.1
MeOH 1630.0 1540.1
EtOH 1644.2 1537.7
IPA 1630.0 1536.0
SF/G (1:3) with glycerin
Untreated 1650.4 1544.2–1548.2
MeOH 1630.0 1536.0
EtOH 1638.1 1536.0
IPA 1630.0 1536.0
SF/G (1:1) with glycerin
Untreated 1625.9 1536.0–1531.9
MeOH 1625.9 1527.8
EtOH 1621.8 1527.8
IPA 1621.8 1536.0
Table 4: Composition of naproxen sodium experimental samples.
Components Silk:gel:glycerin (1:3:3) Matrix Silk ﬁbroin ﬁlm Control ﬁlm
Naproxen sodium (mg) 102.4 250.0 250.0
Gelatin (g) 0.575 0.150 0.250
Silk ﬁbroin (g) 0.192 0.160 0.000
Glycerin (g) 0.575 0.075 0.250
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Figure 2: Dissolution proﬁle of naproxen from SF-containing
matrix ( )a sc o m p a r e dt oS F(  ) and non-SF ( )ﬁ l m .
studied at pH 7.4. The dissolution study results were com-
pared to the release proﬁle of naproxen-loaded SF/gelatin
thin ﬁlms. As shown in Figure 3 SF ﬁlms released 90% of
naproxen sodium within 1 hour of dissolution time at pH
7.4, while SF spray-dried powder released only ∼50% of
naproxen sodium. Approximately 4 hours were required for
SF spray-dried powder to release above 80% of naproxen
sodium. The controlled release observed for naproxen from
the microparticles compared to the fast release rate from the
ﬁlm suggests that the spray-drying process induces a uni-
que change to the structure of the ﬁbroin microparticles
Table 5: SF:NS spray-dried powder blend compositions.
Composition Ratio (w/w)
3% SF —
3% SF:5% EtOH 2:1
3% SF:1% NS 1:1
3% SF:1% NS 1.5:1
3% SF:1% NS 2:1
3% SF:1% NS 3:1
3% SF:1% NS (5% EtOH) 2:1
therebytransformingthemintoprospectivesustainedrelease
vehicles. This provided a starting point for developing SF
spray-dried microparticles as a drug delivery system.
The release of naproxen sodium from spray-dried micro-
particles was also demonstrated using a three-stage dissolu-
tion method at pH 1.4, 4.5 and 7.4. The microparticles with
SF:NS ratios of 1.5:1, 2:1, and 3:1 were observed to have
similarreleaseproﬁleswhilemicroparticleswithSF:NSratio
of 1:1 had slightly higher release proﬁles. At stage 3 (pH
7.4) dissolution, microparticles with diﬀerent SF:NS ratios
performed similarly, releasing up to 80% NS after 3 hours
(Figure 4), while at stage 2 (pH 4.5) the release of the drug
was in the range of 10–20%.
As seen in Figure 4, <25% of drug release from SF
microspheres is observed over the ﬁrst 6 hours at or below
pH 4.5, even at the lowest ratio of SF:NS (1:1). Complete
drug release is only observed after 15 hours at pH 7.4 (25
hours total dissolution time) for all samples analyzed.6 Journal of Drug Delivery
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FTIR analysis was performed on spray-dried microparti-
cles, and the data showed that spray-drying of SF solution
induced β-sheet conformation which was indicated by the
amide I band shifting from 1650cm−1 to 1642/1631cm−1
and amide II from 1536cm−1 to 1516cm−1.H o w e v e r ,m o s t
of the analyzed spray-dried microparticles did not show β-
sheet transition. Samples exposed to 76% relative humidity
for one week showed β-sheet transition as evidenced by the
shift of amide I, II, and III bands (Table 6), thus demon-
strating that exposure to humidity induced β-sheet forma-
tion.
To further investigate the eﬀect of water vapor treatment
on conformation change we subjected the SF:NS spray-dry
powder exposed to 76% relative humidity to 3-stage dissolu-
tion studies. The slight changes in dissolution may suggests
that exposure to moisture contributed to conformational
transition in SF spray-dried powder. SF:NS (2:1) spray
dried powder exposed to 76% relative humidity provides
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Figure 5: Comparison of naproxen release from SF:NS (2:1)
spray-dry powder; non-exposed ( ) to 76% relative humidity
(Control), exposed (♦) to 76% relative humidity and accelerated
stability ( )a t6 0 ◦C.
similar release during stage 1 and 2 dissolution testing, but
showedslightlylowerNSreleaseduringstage3testing.These
data could support the hypothesis that the conformational
transition rate depended on the rearrangement of hydrogen
bonds between SF chains; however additional studies are
needed for conﬁrm this assumption. Previous work has
shown that the conformation transition of SF from random
coil to β-sheet is due to the rearrangement of the hydrogen
bonds between the polypeptide chains and the transition
may be a nucleation-dependent aggregation [21].
The modest eﬀect on dissolution performance observed
(Figure 5) was due to the fact that when both the SF micro-
particles that were initially exposed to water and those not
exposed to water are subjected to the dissolution media, they
can further rearrange their chains making the initial hu-
midity eﬀect negligible.
Additional acceleratedstabilitystudiesonnaproxen-con-
taining SF microparticles were performed. The data pre-
sented in Figure 5 demonstrated that the release proﬁle of
naproxen from SF microparticles exposed to either high hu-
midity (76%) or 60◦C for 1 week is comparable to naproxen
release from control samples.
SEM images of SF microparticles obtained by spray dry-
ing are illustrated in Figure 6.S E MI m a g e s6(a), 6(b), 6(c),
and 6(d) show the microparticles formed from each spray-
dried powder blend. The images provide evidence that
microparticles were formed during the spray drying process.
Asseenin theimagestheSFmicroparticles collapsed,leaving
behind imploded micro-particulates. The addition of 5%
ethanol to microparticles loaded with naproxen and control
blends (refered to as (c) and (d) in Figure 6) was shown to
produce microparticles that are less aggregated and more
smooth, on average, which is possibly attributed to an
accelerated evaporation process in the presence of alcohol.
Further studies of spray-drying conditions are required to
address the observation of collapsed SF microparticles. The
volume, intensity, and number weighted analysis with the
DLS instrument showed that the mean particle size forJournal of Drug Delivery 7
Table 6: FT-IR comparison of amide I, II, and III shifts in SF powder blends exposed to 76% humidity.
Composition Amide I (cm−1)A m i d e I I ( c m −1)A m i d e I I I ( c m −1)
SF:NS (1:1) 76% humidity 1658.2/1629.5 1548.3/1515.7 1264.0/1230.5
SF:NS (1.5:1) 76% humidity 1656.6/1629.9 1538.4/1515.9 1262.6/1228.7
SF:NS (1:1) no humidity 1658.3 1546.6 1230.0
40µm 700x
SF only
(a)
40µm 700x
SF:NS (2:1)
(b)
40µm 700x
SF w/5% EtOH
(c)
20µm 800x
SF:NS(2:1)w/5% EtOH
(d)
Figure 6: SEM images of spray-dried microparticles. SF solution with spray-dried microparticles (a), SF:NS (2:1) blend spray-dried
microparticles (b), SF solution with additional 5% ethanol spray dried microparticles (c), and SF:NS (2:1) blend with additional 5%
ethanol spray dried microparticles (d).
the SF:NS (2:1) microparticles was 26.05 ± 1.92μm. This
is in close agreement with the particle size established by the
SEM images.
As e r i e so fS E Mi m a g e s( Figure 7)w e r ea c q u i r e df o r
diﬀerent spray-dried microparticles remaining after 3-stage
dissolution experiments at pH 1.4, 4.5 and 7.4. The micro-
particles were retrieved from the dissolution vessel after the
endpoint at pH 7.4 and dried before SEM analysis. SEM
Images 7(a),a n d7(b) represent dried SF samples that re-
mained as a compact porous matrix.
4. Discussion
4.1.SilkFibroinProcessing. Naturalsilkﬁbersdissolveonlyin
a limited number of solvents, compared to globular proteins,
because of the presence in ﬁbroin of a large amount of intra-
and intermolecular hydrogen bonds and its high crystallinity
and speciﬁc physicochemical properties. The isoelectric
point of ﬁbroin varies in the range pH 3.6–5.2, depending on
theconditions of solution preparation [22].Fibroindissolves
in concentrated aqueous solutions of acids (phosphoric, for-
mic, sulfuric, and hydrochloric) and in concentrated aque-
ous, organic, and aqueous-organic solutions of salts [LiCNS,
LiBr, CaCl2,C a ( C N S ) 2,Z n C l 2,N H 4CNS, CuSO4 +N H 4OH,
Ca(NO3)2].Themaindisadvantagesofsalt-containingaque-
ous, aqueous-organic, and organic solutions of ﬁbroin are
the long preparation time (aqueous solutions of ﬁbroin
should be dialyzed for several days). It should be noted
that the concentrations of salts in such solutions reach the
saturation limit. It was reported [23] that the eﬃciency of
aqueous salt systems depends on the salt concentration and
increases in the following order: for anions, sulfate < citrate
< tartrate < acetate < chloride < nitrite < bromide < iodide
< thiocyanate < dichloroacetate; for cations, Ca2+ < Sr2+ <
Ba2+ < Li+ < Zn2+. A 75:25 (weight ratio) mixture of
Ca(NO)2 ·4H2O and absolute methanol was used earlier for
dissolving Bombyx mori silk [24, 25] as it has the strongest
dissolving capacity for the SF.8 Journal of Drug Delivery
20µm 1200x
(a)
50µm 300x
(b)
Figure 7: SEM images obtained from diﬀerent spray-dried microparticles extracted with diﬀerent dissolution media after in vitro release
study. SF:NS (2:1) porous matrix remaining from macroparticles after dissolution ((a) and (b)).
Some solvent systems containing LiBr, LiCNS, and
Ca(CNS)2 are unfavorable because LiBr, LiCNS, and
Ca(CNS)2 are classiﬁed as toxic chemicals. Hence, in this
study two solvent systems CaCl2 :EtOH:H2O( 1:2:8m o l e
ratio) and Ca(NO)2 ·4H2O were utilized for SF processing.
Since puriﬁcation of SF by dialysis usually takes 3-4
days and is applicable only for small batches of SF solution,
we attempted to develop a scalable process using Sephadex
G-25 media as described in the literature [19]. Eﬀective
chromatographic separation of SF from salt in solution was
demonstrated by the data shown in Figure 1.B o t hU Va b -
sorbance and conductivity measurements for detecting SF
and CaCl2, respectively, were quick and eﬀective techniques
for diﬀerentiating between the two solution components.
Analysis of solids content upon drying provided an eﬀective
means of quantifying sample mass in each fraction collected,
when combined with the latter experimental techniques to
determinethecompositionofeachfraction.Highyield(95%
recovery of SF protein) and high productivity (>98% salt
removal in <2hrs.)shownhereinforSephadexcolumnchro-
matography provide a promising alternative to conventional
SF puriﬁcation by dialysis. Puriﬁcation of SF solutions by
Sephadex G-25 column chromatography could be an eﬀec-
tive and industrially scalable chemical process. However, fur-
ther optimization and analysis need to be performed for
utilizing SF in pharmaceutical development. In addition,
Sephadex media can be ﬂushed and reused, thereby reducing
development costs associated with puriﬁcation of SF solu-
tions.
4.2. Design of SF-Based Controlled Release Systems. SF is do-
minated in composition by the amino acids glycine, alanine
and serine which tend to form antiparallel β-sheets or
crystals through hydrogen bonding and hydrophobic inter-
actions. Upon gelation a random coil structure of the SF
transformed into β-sheet structure. Several factors aﬀect the
gelation of the SF aqueous solutions. Many factors such as
temperature, SF concentration, shear force, metallic ions,
Ca2+, pH, treatment with low dielectric constant solvents
and poly(ethylene oxide) [21, 26] are thought to aﬀect the
conformation transition. With increase in SF content and
temperature, physical cross-linking among SF chains formed
more easily. Ca2+ ions accelerated these interactions through
the hydrophilic blocks at the chain ends [27].
It is well known and reported in the literature [14] that
the addition of methanol to SF induces aggregation (dehy-
dration), which drives the structuraltransition fromrandom
coil to β-sheet. It was demonstrated [28, 29] that upon
methanol-induced crystallization, the SF β-sheet network
stabilizes SF/gelatin hydrogels at elevated temperatures. The
transition of regenerated SF ﬁlms from random coil to β-
sheet has been reported [30] after treatment with methanol,
ethanol, and 2-propanol. It was also demonstrated [31] that
the rate of gelation of SF was dependent upon glycerol
content and/or SF content and addition of glycerol to the SF
solution accelerated this rate.
In our research, we investigated the eﬀect of dehydra-
ting solvents (methanol, ethanol, isopropyl alcohol, and gly-
cerin) on formation of β-sheets in SF/gelatin blends and de-
monstrated that the treatment with glycerin is also eﬀective
for the transformation of silk I to II which is in agreement
with the literature data [32]. The presence of glycerin in the
matrix can trigger β-sheet induction as seen from Table 3
at the ratio of SF/gelatin ∼1:1. Since the β-sheet formation
did not occur in experiments with SF-to-gelatin ratio of 1:3,
it is suggested that the ratio of SF to gelatin is also critical
for the β-sheet formation. In the presence of glycerin, for
the SF/gelatin 1:1 blend, untreated ﬁlms exhibit the ab-
sorption bands characteristic of the β-sheet structure. In this
case the FTIR spectra possess strong absorption bands at
1625.9cm−1–1621.8cm−1 and 1536cm−1–1531.9cm−1,c o r -
responding to the amide I and amide II peaks, respectively.
The induced crystallization of SF-containing ﬁlms had
an impact on the release proﬁle of the model drug napro-
xen sodium as evidenced by dissolution studies perform-
ed on naproxen-sodium-loaded ﬁlms. It was shown that no
burst eﬀect was observed for matrix containing SF:gela-
tin:glycerin in the ratio of 1:3:3 compared to ﬁlms con-
taining gelatin alone or silk:gelatin (1:1.5) only which re-
leased almost 80% of the drug within the ﬁrst 15 minutes
(Figure 2). The inﬂuence of glycerin-induced SF/gelatinJournal of Drug Delivery 9
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Figure 8: FTIR spectra of SF/gelatin/glycerin matrix.
crystallization on structure and properties was ascertained
by dissolution studies of SF containing controlled release
matrixes (Figure 2). The β-sheet content in the SF matrixes
wasassessedbyFTIRandillustratedinFigure 8.Twomaxima
on spectra reﬂect the characteristic bands of noncrystallized
biopolymer (gelatin) in the matrix and crystallized SF. The
amide I peak, which reﬂects the stretching of C=Og r o u p
along the SF backbone, is shifted from 1655 to 1630cm−1,
while the gelatin exhibit, the absorption band at 1654cm−1
(amide I).
Release behavior of the model drug at diﬀerent loading
from spray-dried microparticles was studied using 3-stage
dissolution testing conditions. In our study it was observed
that the release proﬁle was not dependant on the naproxen-
to-SF ratios in the range of 3:1 to 1:1 or treatment with
dehydrating solvent (ethanol) demonstrating that spray-
drying method accelerated the transition from random coil
to the β-sheet structure of microparticles, which is in agree-
ment with the literature data [19].
Our data obtained from naproxen-loaded, spray-dried
microparticles, matrices, and ﬁlms demonstrated a promis-
ing approach for creating a new platform for controlled drug
delivery.
5. Conclusions
It has been demonstrated that the conformational transition
of SF from random coil to β-sheet in blends with gelatin
obtained by spray-drying or induced by solvents could be
u s e dt og e n e r a t eap o r o u sm a t r i x .T h ed e v e l o p m e n to fS F -
containing blends in which SF is crystallized yields drug
delivery system allowing for controlled release of the drug.
Further studies will be performed on SF-containing matrixes
and microparticles to explore feasibility for delivering diﬀer-
ent classes of drugs, in particular macromolecular drugs for
site-speciﬁc delivery.
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